• Users Online: 924
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login

  Article Access Statistics

Year : 2021 | Volume:  34 | Issue Number:  2 | Page:  90-91

SELECTED SUMMARY

Short-duration adjuvant trastuzumab therapy in human epidermal growth factor receptor 2-positive breast cancers: Has its time come?
Gogia Ajay, Mittal Abhenil, Sharma Atul, Sagiraju Hari Krishna Raju

Number of times this article was viewed 226
Number of times this article has been printed  from the site 16
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0
Back To Article

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Ted Talks / Other Talks